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Expression of inducible-NOS in human glomerulonephritis: The pos-
sible source is infiltrating monocytes/macrophages. Nitric oxide (NO) is a
biological mediator which is synthesized from L-arginine by a family of
nitric oxide synthases (NOS). In this paper, we have studied the expression
of the inducible NO synthase (iNOS) in the tissues of the human kidney
at the mRNA level by RT-PCR assay and at the protein level by an
immunohistochemistry technique using a specific anti-macrophage NOS
monoclonal antibody. Biopsied renal tissues from patients with IgA
nephropathy (IgAN; 28 cases) and with non-IgA mesangial proliferative
glomerulonephritis (PGN;12 cases), and normal renal tissues obtained
from kidneys removed for malignancies (11 cases) were included in this
experiment. 1NOS message was present in about 73% tissues from IgAN
and PGN patients, which was supported by histochemical findings and the
iNOS positive cells were predominantly in the tubulointerstitial areas
where infiltration of monocytes/macrophages was abundant. The iNOS
positive tissues were also strongly positive for CD14, INF-y and TNF-a
mRNA expression. In our in Vitro study, iNOS expression was found only
in cytokines (INF-y and TNF-a) stimulated monocytes/macrophages but
not in lymphocytes and neutrophils. Normal renal tissues did not show any
1NOS expression either at the mRNA level or at the protein level in this
study. Clinical and histological data showed that decreased renal function
and tubulointerstitial damage were greater in the iNOS expressing pa-
tients. This study demonstrates that there is some in vivo induction for
iNOS expression, likely to be mediated by cytokines, for local NO
production that might be involved in the initiation and/or progression of
mesangial proliferative glomerulonephritis.
Studies have shown that renal tissue synthesizes nitric oxide
(NO) in various models of experimental glomerulonephritis [1, 21,
although its pathophysiological role and source are still under
investigation. Previous data have demonstrated that peak NO
production coincided with the main influx of macrophages in
nephritic tissues, and was inhibited by in vivo macrophage deple-
tion in experimental glomerulonephritis [11. This suggested that
macrophages that are known to produce NO on activation [3]
were the source of renal NO. Monocytes/macrophages have been
known to be involved in the pathogenesis of tissue injury in
various types of glomerulonephritis [4—61. In mesangial prolifer-
ative glomerulonephritis, monocyte/macrophage infiltration
causes interstitial/glomerular hypercellularity and tissue damage.
Although several cytokines can activate monocytes/macrophages
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during the initiation of the immune response, the major T
cell-derived cytokine involved in the activation is interferon-y
(INF-y), and its cooperation with other cytokines (produced in an
autocrine or paracrine fashion) has been shown to increase
immune and inflammatory responses [7]. Tumor necrosis factor-a
(TNF-a) is considered as the most essential cytokine for cooper-
ation with INF-y [8]. The synergistic interaction between INF-y
and TNF-a in the expression of iNOS in human monocytic cell
lines has been reported previously [9]. In addition, experimental
animal data have shown that glomeruli infiltrating monocytes/
macrophages produce NO when appropriately stimulated with a
combination of several cytokines [2]. However, it is not known
whether infiltrating monocytes/macrophages in human glomeru-
lonephritis produce iNOS in vivo or not, and until now there was
no direct evidence of iNOS expression in human renal tissue, even
though abnormal expression of inducible nitric oxide synthase
(iNOS) has been reported in experimental renal disease models
[10, 11]. Thus, it is necessary to elucidate the source and mecha-
nism(s) regarding iNOS expression and their implication in
human glomerulonephritis. This study was undertaken to examine
the evidence for in vivo expression of iNOS in human renal tissues
with their distribution and clinical significance in mesangial
proliferative glomerulonephritis.
Methods
Subjects
This study protocol was duly approved by the Ethical Commit-
tee of Tokai University, and informed consent was obtained from
all individuals after explaining the purpose of the study. Open
renal biopsied tissues from 40 patients (IgAN 28, PGN = 12)
were included in this study after exclusion of systemic diseases
such as Henoch Schonlein purpura, lupus erythematosus, liver
cirrhosis and diabetes mellitus. The parts of the renal tissue
remaining after routine histological study for diagnosis (light,
immunofluorescence and electron microscopy) were used in this
study. The advantages and detailed procedures of open renal
biopsy have been reported elsewhere [121. Normal renal tissue
was obtained from 11 different kidneys nephrectomized due to
renal cell carcinoma. None of the patients was on any drugs
known to interfere with iNOS expression at the time of biopsy.
Clinical status of both IgAN and PGN patients was evaluated by
proteinuria, hematuria, blood urea nitrogen (BUN), serum creat-
mine (SCr) and GFR values at the time of biopsy. The renal tissues
were frozen immediately and stored at —80°C until further use.
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Tissue studies
Renal tissues data were analyzed and classified in a semiquan-
titative way without knowledge of patient identity. Optical micros-
copy features in the glomeruli (mesangial proliferation, mesangial
sclerosis and crescent formation/capsular adhesion), tubulointer-
stitium (tubular atrophy and interstitial fibrosis), and vessels were
assessed with respect to the severity of lesion. The degree of
tubular atrophy and interstitial fibrosis was evaluated and graded
on a scale of minus (—) for absent, + for mild, + + for moderate
and + + + for severe lesion.
Cell data analysis
Snap-frozen sections were stained by an indirect immunoper-
oxidase method using CD14 and CD68, anti-human macrophage
antibodies. Cells were separately counted in the interstitium and
the glomeruli in the same way as described previously [13, 14].
Briefly, cells in the interstitium were counted using an eyepiece
graticule to identify 10 microscopic fields (400 X high power
field), each 0.05 mm and evaluated semiquantitatively. A score of
+ + + indicates an infiltrate of 0.075 mm; + +, an interstitial
infiltration of 0.05 to 0.075 mm; and +, an infiltration of <0.05
mm. The number of glomeruli available for counting varied from
15 to 75 per section. For each section, both the number of the
intraglomerular cells and the number of glomeruli were counted.
Extracapillary cells or cells in crescents were excluded in the
count. Finally the number of positive cells was expressed as
number of cells per glomerular cross-section.
Reagents and monoclonal antibodies
Reagents used in this study included: Hemaceel® (35%; Be-
hring Inst., Erbehring, Germany); Ficoll-Hypaque (Pharmacia
LKB Biotechnology Inc., Piscataway, NJ, USA); RPMI 1640
media (Gibco, Grand Island, NY, USA); recombinant human
tumor necrosis factor-alpha (TNF-cv; R&D Systems, Minneapolis,
MN, USA); and human interferon gamma (INF-y; Amgen). The
antibodies used were mouse anti-macrophage NOS monoclonal
antibody (iNOS; Transduction Laboratories, Lexington, KY,
USA); and mouse anti-human macrophage antibodies, CD68 and
CD14 ((Dako A/S, Denmark).
RT-PCR protocol
Total RNA was prepared from renal tissue homogenates using
Isogen® (Wako Chemical Co., Osaka, Japan) based on a guani-
dinium-phenol-chloroform extraction method [15]. Three micro-
grams of RNA was reverse transcribed with an Oligo (dT)18
primer in 50 mM Tris-HC1 (pH 8.3), 75 mM KC1, 3 mrvi MgC12 and
0.5 mM dNTP mixture using 40 units of M-MLV R reverse
transcriptase in the presence of 20 units of recombinant RNase
inhibitor (Clontech Laboratories, Inc., 4030 Fabion Way, Palo
Alto, CA, USA). We also prepared cDNA from isolated glomeruli
which were isolated from human biopsied renal tissues applying
the microdissection method as previously described [16] with a
slight modification. The microdissection solution (solution 1) was
a Hepes-buffer solution of the following concentrations (millimo-
lar): 135 NaCI, 5 KC1, 1 Na2HPO4 (7 H20), 12 MgSO4 (7 H20),
2 CaCl2, 1.2 Na2SO4, 55 glucose, and 5 Hepes added after pH
adjustment to 7.4 by NaOH. The solution 2 was of the same
composition as the microdissection solution (solution 1), except
that it contained 5% vanadyl ribonuclease complex (VRC; Life
Table 1. Oligonucleotide primers used in eDNA amplification
Transcript
primer
Predicted
size bp Sequence
GAPDH, '
GAPDH, 250
5'-GCG ACG AAG GCC GTG TGC GTG-3'
5'-CGC TGC TFC CGG CAC ACG CAC-3'
CD14, 5'
CD14, 3
,,50 5'-ACA ATC CTG GAC TGG GCG AAC-3'5'-TFG GAG CAG CAC CAG GGT TCC-3'
iNOS, 5'
iNOS, 3 506
5'-CTA TGC TGG CTA CCA GAT GC-3'
5'-CCA TGA TGG TCA CAT TCT GC-3'
INF-y, 5'
INF-y, 3' 476
5'-llTG GCT TFT CAG CTC TGC-3'
5'-CTG GGA TGC TCT TCG ACC-3'
TNF-a, 5'
TNF-a, 3'
5'-CAG AGO GAA GAG UC CCC AG-3'
5'-CCT TGG TCT GGT AGG AGA CG-3'
Technologies). Amplification in each PCR reaction was carried
out in a final volume of 25 tl (10 mr't Tris-HC1, 50 mrvi KCI, 1,5
mM MgC12 and 0.2 mM of all four dNTPs) containing 1 .iJ (20 LM)
of each sequence specific primer and 1 il of cDNA template with
two units of AmpliTaq DNA Polymerase (Perkin-Elmer Cetus,
Norwalk, CT, USA). Based on the human genomic sequence as
previously reported, oligonucleotide primers were designed using
the EMBL database (Table 1) and synthesized products were
obtained from TAKARA Biomedicals, Japan. The PCR amplifi-
cation reactions consisted of one minute denaturing at 94°C, one
minute annealing at 62°C and 1.5 minutes extension at 70°C. In a
preliminary experiment 30, 35 and 40 PCR cycles were shown to
be appropriate for optimal fluorescence of GAPDH and CD14,
INF-y and TNF-a, and iNOS genes, respectively. Ten microliters
of each PCR product was analyzed by electrophoresis on a 2%
agarose gel (TAKARA Biomedicals) containing ethidium bro-
mide (0.5 pA/mi) in Tris-acetate-EDTA (TAE) buffer (pH 8.0).
The gel was then photographed on Polaroid film (Polaroid Co.,
Cambridge, MA, USA).
Cell preparation
Peripheral blood mononuclear cells (PBMC) and neutrophils
were obtained from healthy volunteers by Ficoll-Hypaque density-
gradient centrifugation as described earlier [17, 18]. Isolated cells
were washed in RPMI 1640 media containing 2 mivi L-glutamine,
100 U/mi penicillin, 100 tg/ml streptomycin and 5 mvi HEPES
buffer (Gibco). Monocyte and lymphocyte fractions were isolated
from PBMC by adherent procedures as described previously [19].
Monocyte purity was > 90% as determined by morphology
(cytospin test, duff-quick stain, Green Cross Co., Japan) and flow
cytometric analysis staining with a monoclonal antibody against
CD14 antigen. The viability of monocytes, lymphocytes and
neutrophils was more than 98% as assessed by Trypan blue
exclusion. Monocytes (2 X 10), lymphocytes (2 X 10) and
neutrophils (2 X 10) were incubated in RPMI 1640 media
supplemented with 20% (vol/vol) heat-inactivated fetal calf serum
(FCS) and antibiotics in Eppendorf vials (Eppendorf, Hamburg,
Germany) in the presence or absence of INF-y (200 U/mI) and
TNF-a (500 U/mI) at 37°C with 5% CO2 before extraction of
RNA. Standard culturing conditions, time and optimal cytokine
concentrations were established from preliminary experiments.
All procedures used in this study were performed with endotoxin
free media and supplies to avoid non-specific activation of cells.
At the indicated times cells were washed in antibiotics supple-
mented RPMI media and the cell-pellet was frozen at —80°C by
I
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Isogen treatment until further analysis. Total mRNA of incubated
cells was prepared using the same procedures as described in the
RT-PCR protocol.
Sequence of iWOS PCR products
The PCR amplified iNOS fragments from renal tissue and
monocytes/macrophages were purified from agarose gel. Sequenc-
ing was performed by direct cycle sequencing on an ABI 373S
automated sequencer (Applied Biosystems Inc.) using Dye Ter-
minator cycle sequencing kit (Perkin-Elmer Corp.)
Histochemistiy
Fresh frozen tissue sections (4 jxm) were stained by the ABC
method briefly summarized as follows: (1) fixation in acetone; (2)
washing in 10 msi PBS (phosphate buffered saline), pH 7.4; (3)
incubation with PBS containing 2% horse normal serum; (4) PBS
washing; (5) avidin and biotin blocking; (6) PBS washing; (7)
incubation with primary antibody (mouse anti-MAC NOS, iNOS),
diluted in PBS + 0.2% BSA (bovine serum albumin); (8) washing
in PBS; (9) incubation with secondary antibody (anti-mouse IgG,
Vectastin ABC kit); (10) PBS washing; (11) quenching of endog-
enous peroxidase activity with 0.3% H202 in methanol; (12)
washing in PBS; (13) incubation with avidin-biotin-peroxidase
complex (Vector Laboratories); (14) washing in PBS and Tris-
HC1 buffer 50 mtvt, pH 7.6; (15) incubation with substrate solution,
0.5 mg 3' 3 diaminobenzidine tetrahydrochloride (Wako Chemi-
cal In., Japan) per ml Tris-HCI buffer containing 0.025% H202;
(16) counter staining in Mayer's hematoxylin; and (17) dehydra-
tion and mounting for microscopy.
Statistical analysis
The Mann-Whitney U-test and Fisher test were employed to
determine the P values. The level of significance was set at P <
0.05.
Results
iNOS mRNA expression in the whole renal tissues and in the
glomendi
Under identical conditions, a constant amount of cDNA from
each biopsy specimen was amplified by the PCR method and the
integrated optical intensity of amplified target gene fluorescence
in the ethidium bromide-stained was analyzed. The intensity of
the amplified house-keeping gene, GAPDH was almost uniform
in all healthy and patient tissues (Fig. 1), confirming that the
efficiency of reverse transcription did not vary significantly be-
tween samples. The target gene iNOS (size 506 bp) was appeared
in 20 cases out of 28 IgAN (71%) and 9 cases out of 12 PGN
patients (75%). There was no detectable iNOS signal in the
healthy control tissues. The iNOS positive samples were also
strongly positive for CD14, INF-y and TNF-c genes. In some
iNOS negative tissues, certain inconsistent PCR products for
CDI4, INF-y and TNF-a were observed. Furthermore, we have
extended our studies to iNOS mRNA expression in the same
amount of eDNA prepared from isolated glomeruli from 27 renal
specimens (13 IgAN; 10 PGN; and 4 healthy control). No
detectable iNOS message was observed in the glomeruli samples,
even when using the highest concentration of starting eDNA
template with up to 40 PCR cycles, whereas the housekeeping
gene GAPDH expression was almost uniform in all samples (data
not shown).
In vitro study
The influence of INF-y and TNF-a on the induction of iNOS
expression at its mRNA in monocytes/macrophages, lymphocytes
and neutrophils obtained from healthy personnel is demonstrated
in Figure 2. iNOS mRNA was not constitutively expressed in
either cell, but was induced only in monocytes/macrophages by
combined treatment with INF-y and TNF-a. Neither INF-y nor
TNF-a alone induced detectable iNOS mRNA expression. In
monocytes a single iNOS mRNA band first appeared four hours
after stimulation, peaked at 12 hours, and was barely detectable
after further extension of incubation time (24 hr; data not shown).
No mRNA signal for iNOS was detected in either stimulated or
unstimulated lymphocytes and neutrophils. The specificity of the
PCR products from renal tissues and monocytes/macrophages was
confirmed by partial sequence analysis of amplified iNOS eDNA
1 2 3 4
GAPDH -
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TNF-a -
Fig. 1. Representative expression of GAPDH, CDI4, iNOS, INF-y and
TNF-a mRNA in renal tissues detected by PCR analysis. PCR products of
normal tissue (lane 1) obtained from control renal tissue; mildly damaged
tissue (lane 2), moderately damaged tissue (lane 3), and severely damaged
tissue (lane 4) obtained from IgAN and PGN patients.
U1
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Fig. 2. Analysis of iNOS mRNA in human
monocytes/macrophages, lymphocytes and
neutrophils after 12 hours incubation period.
Data show one representative experiment out
of three. Monocytes/macrophages: unstimulated
(lane 1); INF-y and TNF-a stimulated (lane 2).
Lymphocytes: unstimulated (lane 3); INF-y and
TNF-a stimulated (lane 4). Neutrophils:
unstimulated (lane 5); INF-y and TNF-a
stimulated (lane 6).
Fig. 3. Localization of iNOS protein in the renal biop3y samples from patients with severe tissue damage (A) and mild tissue damage (B) (X 200). The
majority of iNOS expressing cells appear positive for the macrophage marker CD14 (C) (x 400). Absence of iNOS protein in a negative control tissue
from patient (D) (X 200).
which displayed a full homology to the nucleotide sequence of
hepatocyte iNOS (data not shown).
Localization of iNOS
Immunohistochemical staining showed that iNOS positive cells
were predominantly in the tubulointerstitial areas of renal tissues
(Fig. 3 A, B), where monocyte/macrophage infiltration was abun-
dant. In the serial tissue section staining, most of the iNOS
expressing cells appeared to be CD14 positive (Fig. 3C) as well as
CD68 positive (not shown) monocytes/macrophages which were
present mostly in the interstitial areas. Tissues from normal
kidney or diseased kidney without or with poor cell infiltration did
not show iNOS staining. No remarkable staining for iNOS was
observed in the glomerular region, although some weak focal
staining was found in some glomeruli over visceral glomerular
epithelial cells and occasional capsular cells. Weak focal staining
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Table 2. Comparison of clinical laboratory data in IgA and PGN
patients according to iNOS expression
iNOS expression
P valuePositive Negative
Patients N
GFR mI/mm
BUN mg/mi
Sr mg/mi
28
67.00 24.21
16.60 5.20
1.13 0.47
12
85.70 21.10
12.52 3.90
0.80 0.16
<0.05
<0.03
<0.02
in occasional cortical tubular epithelium in areas with interstitial
inflammation was also observed. However, large blood vessel
endothelium and smooth muscle were consistently negative.
To determine the relevance of iNOS expression in nephritic
tissue to renal pathophysiology, clinical data of all patients at the
time of renal biopsy were examined. The specimens which ex-
pressed a detectable iNOS at the mRNA level were considered as
iNOS positive group. SCr was significantly decreased in patients
who expressed iNOS compared with those who did not. BUN and
serum creatinine were significantly higher in the iNOS positive
group of patients (Table 2). Urinary protein excretion and hema-
tuna did not show statistical significance when compared between
the iNOS positive and negative groups (data not shown). The
severity of tubulointerstitial damage was significantly greater in
the iNOS positive group than that in the negative group (Fig. 5A;
P < 0.01). iNOS expression also showed a direct correlation with
the amount of interstitial monocyte/macrophage infiltration (Fig.
SB; P < 0.01). In other wards, tubulointerstitial damage was
related to the amount of monocyte/macrophage infiltration in the
interstitium. One out of five (20%), 16 out of 20 (80%) and 12 out
of 13 (92%) patients with mild, moderate and severely tubuloin-
terstitial damage, respectively, were positive for iNOS expression.
Discussion
Nitric oxide (NO) research has quickly become an intense area
of study in a wide variety of disciplines [20, 21]. In this report, it
is demonstrated that there is in vivo induction of iNOS in human
mesangial proliferative glomerulonephritis. The use of both im-
munohistochemistry and RT-PCR techniques provided strong
evidence for the existence and localization of iNOS in human
nephritic renal tissues, specifically in the tubulointerstitial areas
where monocytes/macrophages were abundant. Until now, NO
synthesis by nephritic kidney was inferred mainly from experimen-
tal studies either in vitro [2] or in vivo [10]. The isoform of iNOS
we have detected is known to be induced by cytokines involved in
the mediation of tissue injury in glomerulonephritis [22]. In-
creased iNOS expression was correlated with the severity of renal
dysfunction, such as increased blood urea nitrogen and serum
creatinine levels with decreased Srvalues, and interstitial tissue
damage, suggesting the cytostatic/cytotoxic effect of NO. Al-
though the mechanism(s) by which NO promotes tissue damage
have not been explained in this experiment, it might be mediated
through a reaction with superoxide which production has been
shown to be increased in IgAN and PGN patients in our previous
studies [17, 18], to form peroxynitrite radicals [23, 24] or by direct
binding of NO to iron sulphur-containing enzymes such as
aconitase or those of the mitochondrial electron transport chain.
The present results demonstrate an inducible enzymatic pathway
of NO production in the human nephritic tissues which implies
tissue damage and renal dysfunction. Our data suggested that the
iNOS expression may be disease associated, since there was no
detectable iNOS expression in normal renal tissues in our study,
but whether it is a cause or consequence of the disease has not
been established.
The source of NO in human GN is of some interest. There are
two possible sources, either the infiltrating cells or the intrinsic
cells such as mesangial cells, smooth muscle cells, endothelial
cells, and tubular cells. In our histochemical study, parallel
staining for monocytes/macrophages showed restriction of iNOS
expression to interstitial areas of tissue infiltration by monocytes/
macrophages, whereas no convincing staining either for macro-
phages or for iNOS was observed in the glomerular regions.
Moreover, isolated glomeruli samples also did not show any
detectable iNOS expression at the mRNA level. In contrast,
previous in vitro or experimental studies demonstrated the induc-
tion of iNOS gene in the mesangial cells [25, 26], endothelial cells
[27] and tubular cells [28]. At present, the cause(s) of these
contradictory results is unknown, but a few points may take into
consideration. Firstly, the suggested capacity of mesangial cells or
tubular cells to induce NO may be a cell culture-dependent
phenomenon differing from that of in vivo conditions. Such as
under the influence of cytokines, mesangial cells may gain prop-
erties that make them act partially as macrophages as suggested
by Pfeilschifter, Kunz and Muhl [29]. Secondly, the in vivo level of
iNOS expression may be too low to be detected, probably due to
a low sensitivity of the detection system. Moreover, our own
experience and previous reports showed the presence of a very
few number of intraglomerular monocytes/macrophages (0.63 to
1.10/glomerulus) in IgAN and PGN that did not differ significantly
from that in normal glomeruli (0.5 to 0.9/glomerulus) [14, 30]. In
addition, the observation of intraglomerular monocyte/macro-
phage infiltration depends mainly on the stage of the disease,
especially during the acute phase, as reported previously [1, 2],
whereas all patients included in this study were in the chronically
inactive stage of their disease. Thirdly, some iNOS expression
inhibitors may present in the glomeruli, such as TGF-j3 [31], which
expression was shown to be increased in glomeruli of IgAN
patients in our another study [32]. However, the concomitant
participation of intrinsic glomerular cells in the synthesis/release
of NO during glomerular inflammation cannot be excluded [26],
since iNOS induction in different cells may peak at different time
points, and renal biopsy gives only a static image of an evolving
process of disease. A prior sequential study of the development of
experimental tubulointerstitial disease revealed the large variabil-
ity in the inflammatory cells depending on the time of biopsy [33].
However, the difference in the regulation of iNOS in vivo in
comparison to that in vitro again highlights the difficulties in
applying knowledge from experience in vitro to that of in vivo, and
a further detailed study is warranted to clarify this point.
In fact, whether the mouse iNOS is human specific or not is very
critical to conclude in this stage. In our in vitro study, monocyte/
macrophage morphology cells in the cytokine-treated PBMC
stained positively for mouse anti-macrophage NOS antibody (Fig.
4). Moreover, Geller et a! [34] found 80% amino acid homology
between human hepatocyte iNOS and murine macrophage iNOS.
In addition, the human specificity of this antibody was tested by
Western blotting on the human A431 and human HeLa cells by
the manufacturer (Transduction Laboratories), suggesting that
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Fig. 4. Staining of cytokine stimulated peripheral
blood mononuclear cells (PBMC) with mouse
anti-macrophage NOS antibody. Anti-
macrophage NOS staining cells display
monocytes/macrophages morphology, whereas
lymphoid morphology cells do not show any
staining (A). The absence of NOS staining in
the cytokine-treated PBMC without the
application of first antibody (B). Both positive
and negative monocytes/macrophages cells are
shown by arrows.
the antibody raised against mouse macrophages can recognize a
similar protein in the human tissue.
It has been demonstrated that several cytokines are involved in
inflammatory renal tissues which cause cellular infiltration in the
tissue. Our and others previous reports [14, 35] showed that a
substantial number of monocytes/macrophages was always
present with T cells in the interstitial areas of IgAN and PGN
patients. This high degree of correlation between T cells and
monocytes supports the hypothesis that activated T-cell derived
cytokines may contribute to the interstitial influx of monocytes,
and subsequent activation of the cells for later events such as
iNOS induction and thus contribute to the tissue damage and
renal dysfunction as observed in this study.
So far, reports on the existence of iNOS in human monocytes!
macrophages are conflicting, if compared to the established data
in rodent macrophages. Our data showed that human monocytes!
macrophages are capable of producing NO by inducing iNOS in
response to the inflammatory cytokines INF-y and TNF-s, and
these are consistent with the previous reports [36, 37]. In contrast,
Schneemann et al [38] and others [39] failed to detect NO
production by human macrophages. At present it is not clear why
there is such a discrepancy. However, it is likely that human
monocytes/macrophages produce NO in some selective situations,
perhaps in response to a more complete stimuli, although the
quantity is considerably less than that seen in the murine coun-
terpart, possibly because of less tetrahydrobiopterin production in
human monocytes [40]. Although human monocyte iNOS has not
yet been cloned, a prior report [36] and our partial sequencing
data suggest that the deduced sequencing of iNOS PCR products
from human monocytes/macrophages and renal tissue are almost
identical to that of human hepatocytes iNOS mRNA [34]. Thus,
human monocytes/macrophages iNOS is very homologous, if not
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identical to human hepatocyte iNOS. However, cloning and
complete sequencing of monocytes/macrophages iNOS eDNA is
mandatory for the final determination.
Although the importance of tubulointerstitial changes may be
crucial in glomerular diseases, particularly in relation to progno-
sis, data on the glomerular components are still much greater than
those on the tubules and interstitium. Previous studies have
demonstrated that the level of interstitial mononuclear cell infil-
tration was closely associated with decreased renal function, in
contrast to the lack of statistically significant correlation between
the presence of intraglomerular leukocytes and various renal
indices [14, 41, 42]. Our present data further support the impor-
tance of interstitial infiltrating cells in the tissue injury of inflam-
matory nephritis. However, in addition to the progression of the
primary inflammatory process in the interstitium, the accompany-
ing glomerular inflammation might also be associated with the
decline in kidney function.
In conclusion, this study provides the first, to our knowledge,
direct evidence of in vivo induction of iNOS in human glomeru-
lonephritis. The infiltrating monocytes/macrophages possibly ac-
tivated by inflammatory cytokines during the disease process are
a substantial source of iNOS, and which might participate in the
pathogenesis of this disease through the induction of NO produc-
tion. Therefore, iNOS expression might have an vital impact in the
initiation and/or progression of human glomerulonephritis. Fur-
ther investigation of NO induction and its products may provide
not only a better understanding of cell-mediated glomerulone-
phritis, but may also allow the introduction of new targets for
therapeutic intervention in this disease.
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iNOS positive and negative groups. Abbreviations
are: (—) no lesion, (+) mild lesion, (++)
moderate lesion, and (+ + +) severe lesion.
Symbols are: (LI) normal; (0) IgAN patient;(•) PGN patient. P < 0.01.
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